Craft

SynCore Biotechnology

Stock Price

NT$36.8

2024-10-29

Market Capitalization

NT$1.3 B

2024-10-29

Revenue

NT$23.3 M

FY, 2024

SynCore Biotechnology Summary

Company Summary

Overview
SynCoreBio (杏國新藥股份有限公司) is a biopharmaceutical company engaged in the research and development of drugs. It focuses on oncology, ophthalmology, dermatology, and infectious diseases.
Type
Public
Status
Active
Founded
2008
HQ
TW | view all locations
Website
https://www.syncorebio.com/
Cybersecurity rating
Sectors

Key People

  • Yita Lee, Deputy Chairman

    LocationsView all

    1 location detected

    • Taipei City HQ

      Taiwan

      4f, No. 69, Dongxing Road, Xinyi District

    SynCore Biotechnology Financials

    Summary Financials

    Revenue (Q3, 2025)
    NT$6.5M
    Gross profit (Q3, 2025)
    (NT$1.3M)
    Net income (Q3, 2025)
    (NT$8.0M)
    Cash (Q3, 2025)
    NT$171.3M
    EBIT (Q3, 2025)
    (NT$8.7M)
    Enterprise value
    $1.1B

    Footer menu